Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

European News In Brief

This article was originally published in The Gray Sheet

Executive Summary

EU human tissue regulation: DG Enterprise will likely release an independent human tissue product draft directive in June 2003, arousing European industry concern over the possibility of two separate circulating directives. Eucomed's public policy focus group has responded favorably to DG Sanco's proposed directive setting out quality requirements for processing human tissues and cells, set for approval before 2004. Enterprise's initiative also was well received by industry, since manufacturers are expected to be "treated on the same basis as tissue banks." The Sanco directive, founded on Article 152 under the Amsterdam Treaty, is an EU Health Policy initiative. The DG Enterprise proposal, meanwhile, aims to create an EU-wide regulatory framework for marketing tissue products...

You may also be interested in...



Separate Tissue Product/Transplant Laws Requested To Reduce EU Reg Onus

Investment in European tissue-engineered medical devices will suffer if the European Parliament's report on a proposed directive for human tissue quality and safety standards is not amended, EU stakeholders say

Separate Tissue Product/Transplant Laws Requested To Reduce EU Reg Onus

Investment in European tissue-engineered medical devices will suffer if the European Parliament's report on a proposed directive for human tissue quality and safety standards is not amended, EU stakeholders say

International News In Brief

Siemens AG/Draegerwerk: European Commission opts to extend investigation of German hospital equipment joint venture Jan. 22. Under the deal, Siemens will transfer its ventilator, anesthesia delivery and patient monitoring businesses to Draegerwerk in exchange for a 35% share of wholly owned subsidiary Draeger Medical, which would then be jointly controlled by the two partners. The proposed transaction would lead to a combined ventilator market share that proved sufficient to trigger an in-depth inquiry by the EC, which has four months to issue a final decision on the merger...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017558

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel